Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Draft whole-genome and mitochondrial genome assemblies of <i>Steinernema tarimense</i> and <i>Heterorhabditis</i> sp. XJ-55.

Journal of helminthology·2026
Same author

Preclinical characterization and phase I results of TQB2102, a first-in-class HER2 biparatopic antibody-drug conjugate, in patients with advanced solid tumors.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

[Association between long-term cumulative levels of non-high-density lipoprotein cholesterol and the risk of cardiovascular disease: a prospective cohort study].

Zhonghua yi xue za zhi·2026
Same author

Palliative and supportive care underutilization for patients with locally advanced pancreatic cancer: review of the NCDB.

ESMO gastrointestinal oncology·2026
Same author

Silver Needle Thermal Therapy Improves Mitochondrial Injury in the Skeletal Muscle of MPS Rats by Inhibiting the TRPV1/CaMKII Pathway.

Physiological research·2025
Same author

[Impact of six lipid parameters on cognitive impairment in the elderly Chinese population: a prospective cohort study].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2025

Related Experiment Video

Updated: May 9, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Integration microarray and regulation datasets for Chronic Obstructive Pulmonary Disease.

J-Y Yang1, J Jin, Z Zhang

  • 1Respiratory Department, Shanghai Jiaotong University, Shanghai, China.

European Review for Medical and Pharmacological Sciences
|July 24, 2013
PubMed
Summary
This summary is machine-generated.

This study investigated the gene expression regulation in Chronic Obstructive Pulmonary Disease (COPD). Key transcription factors like STAT1 and NFKB1 were identified as crucial in COPD pathogenesis, offering new treatment targets.

More Related Videos

Lung microRNA Profiling Across the Estrous Cycle in Ozone-exposed Mice
07:07

Lung microRNA Profiling Across the Estrous Cycle in Ozone-exposed Mice

Published on: January 7, 2019

Related Experiment Videos

Last Updated: May 9, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Lung microRNA Profiling Across the Estrous Cycle in Ozone-exposed Mice
07:07

Lung microRNA Profiling Across the Estrous Cycle in Ozone-exposed Mice

Published on: January 7, 2019

Area of Science:

  • * Molecular biology
  • * Bioinformatics
  • * Medical research

Background:

  • * Pulmonary diseases represent a significant global health challenge.
  • * Chronic Obstructive Pulmonary Disease (COPD) is a major contributor to morbidity and mortality.
  • * Understanding the molecular underpinnings of COPD is critical for effective management.

Purpose of the Study:

  • * To elucidate the regulatory mechanisms governing gene expression in COPD.
  • * To identify key pathways and molecular players involved in COPD pathogenesis.
  • * To explore potential therapeutic targets at the gene and pathway levels.

Main Methods:

  • * Analysis of transcriptome profiles to identify differentially expressed genes in COPD.
  • * Construction of gene regulation networks, including TF-target gene and TF-pathway networks.
  • * Development of a pathway crosstalk network to understand inter-pathway interactions.

Main Results:

  • * STAT1, NFKB1, SMAD4, and STAT3 were identified as pivotal in COPD through their involvement in multiple pathways.
  • * The study mapped these key players to specific regulatory networks and pathways.
  • * While pathways were previously linked to COPD, detailed mechanisms remain to be fully elucidated.

Conclusions:

  • * The findings enhance the understanding of COPD's complex molecular mechanisms.
  • * Identified regulatory pathways offer novel therapeutic strategies for COPD treatment.
  • * This research provides a foundation for future investigations into COPD pathogenesis and intervention.